Valuation : Gedeon Richter

Market Cap 2,278B 7.27B 6.25B 5.9B 5.37B 10.04B 695B 10.14B 70.24B 27.03B 352B 27.29B 26.7B 1,120B P/E 2026 *
9.19x
P/E 2027 * 7.86x
Enterprise Value 2,016B 6.43B 5.53B 5.22B 4.75B 8.89B 615B 8.97B 62.15B 23.92B 312B 24.15B 23.62B 991B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.83x
Free-Float
72.87%
Yield 2026 *
4.83%
Yield 2027 * 5.42%
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 31/10/2017
Director of Finance/CFO - 30/04/2025
Chief Operating Officer - 31/12/2018
Director TitleAgeSince
Chairman 78 31/12/2016
Chairman 90 29/02/2024
Director/Board Member 65 25/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 7.27B
-1.13%-3.97%+15.48%+62.77% 46.7B
-1.13%-7.39%+36.30%+109.40% 39.11B
+0.12%-2.09%+7.65%+78.16% 11.66B
-0.53%-2.06%-12.65%+9.75% 11.6B
-0.38%0.00%+19.82%+136.36% 9.19B
+0.32%-2.26%+23.33%+33.23% 7.27B
+0.17%-1.62%+13.53%+211.41% 7.13B
-1.00%-6.83%+33.22%-17.14% 7.15B
-3.13%-4.45%-45.09%+17.23% 5.13B
Average +1.75%-3.09%+10.18%+71.24% 16.1B
Weighted average by Cap. +0.33%-3.63%+17.52%+77.29%

Financials

2026 *2027 *
Net sales 951B 3.04B 2.61B 2.46B 2.24B 4.19B 290B 4.23B 29.33B 11.29B 147B 11.4B 11.15B 468B 1,021B 3.26B 2.8B 2.64B 2.41B 4.5B 311B 4.54B 31.48B 12.11B 158B 12.23B 11.96B 502B
Net income 254B 811M 698M 658M 600M 1.12B 77.57B 1.13B 7.84B 3.02B 39.35B 3.05B 2.98B 125B 291B 927M 797M 752M 685M 1.28B 88.63B 1.29B 8.96B 3.45B 44.96B 3.48B 3.41B 143B
Net Debt -262B -837M -720M -680M -619M -1.16B -80.07B -1.17B -8.09B -3.11B -40.61B -3.14B -3.08B -129B -410B -1.31B -1.13B -1.06B -967M -1.81B -125B -1.82B -12.64B -4.87B -63.44B -4.91B -4.81B -201B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,490.00HUF
Average target price
13,214.57HUF
Spread / Average Target
+5.80%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!